AMRZ Market Analysis

Overview

Fundamentals

P/E ratio26.23Forward 18.98
EPS (TTM)$2.093.6% YoY
Profit margin9.7%BASIC MATERIALS
Market cap$30.35BLarge cap

Wall Street coverage

$64.91median target· current $51.99 (+24.9%)20 analysts

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

Valuation

Forward P/E
18.98
PEG ratio
1.46
P/B
2.29
P/S (TTM)
2.63
EV/EBITDA
13.47

Profitability & growth

ROE (TTM)
10.1%
Operating margin
-3.5%
Revenue growth YoY
4.7%
Dividend yield
0.8%
Beta
Last earnings
May 14, 2026 · Estimate $-0.17 · Reported $-0.21
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Amrize Ltd

Amrize Ltd (AMRZ) is a pioneering technology company specializing in the digital health and wellness sector, committed to revolutionizing healthcare delivery through cutting-edge technologies and data-centric solutions. With a robust emphasis on enhancing patient outcomes and accessibility, Amrize allocates substantial resources to research and development, positioning itself to meet the escalating demand for scalable health innovations. Its strategic initiatives, coupled with a diverse portfolio of products, underscore Amrize's potential as a crucial player in the ongoing transformation of…

Classification

Exchange
NYSE
Country
USA
Currency
USD

Company profile

HQ
GRAFENAUWEG 8, ZUG, SWITZERLAND
Fiscal year end
December
Latest quarter
Mar 31, 2026
Market cap$30.35B
Shares outstanding$553.5M
52W high$65.29
52W low$43.69

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer